CCEL vs SPCE · P/E 490, $39.6M cap vs rev $7.0M
CryoCell International Inc (CCEL) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
CCEL does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the CCEL and SPCE stock pages for the full models.
Not investment advice.